Lymphangioleiomyomatosis: New insights

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1183-1186

  Kalassian, Kenneth G ^a   Doyle, Ramona ^a   Kao, Peter ^a   Ruoss, Stephen ^a   Raffin, Thomas A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EXAMINATION; DIAGNOSTIC ERROR; DISEASE PREDISPOSITION; HUMAN; LEIOMYOMATOSIS; LUNG CANCER; LUNG TRANSPLANTATION; LYMPHANGIOMYOMA; PREMENOPAUSE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SURVIVAL;

EID: 8244228681     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105053     Document Type: Review

References (34)

1. Taylor, J. R., J. Ryu, T. V. Colby, and T. A. Raffin. 1990. Lymphangioleiomyomatosis: clinical course in 32 patients. N. Engl. J. Med. 323:1254-1260.
2. Bonetti, F., M. Pea, G. Martignoni, and G. Zamboni. 1992. PEC and sugar [letter; comment]. Am. J. Surg. Pathol. 16:307-308.
3. Gown, A. M., A. M. Vogel, D. Hoak, F. Gough, and M. A. McNutt. 1986. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am. J. Pathol. 123:195-203.
4. Bonetti, F., P. L. Chiodera, M. Pea, G. Martignoni, F. Bosi, G. Zamboni, and G. M. Mariuzzi. 1993. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis [see comments]. Am. J. Surg. Pathol. 17:1092-1102.
5. Hoon, V., S. N. Thung, M. Kaneko, and P. D. Unger. 1994. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch. Pathol. Lab. Med. 118:732-734.
6. Esclamado, R. M., A. M. Gown, and A. M. Vogel. 1986. Unique proteins defined by monoclonal antibodies specific for human melanoma: some potential clinical applications. Am. J. Surg. 152:376-385.
7. Wagner, S. N., C. Wagner, H. Hofler, M. J. Atkinson, and M. Goos. 1995. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45: identification as melanocyte-specific Pmel 17 cDNA. Lab. Invest. 73:229-235.
8. Kwon, B. S. 1993. Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. J. Invest. Dermatol. 100(Suppl. 2):134S-140S.
9. Kwon, B. S., C. Chintamaneni, C. A. Kozak, N. G. Copeland, D. J. Gilbert, N. Jenkins, D. Barton, U. Francke, Y. Kobayashi, and K. K. Kim. 1991. A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl. Acad. Sci. U.S.A. 88: 9228-9232.
10. Adema, G. J., A. J. de Boer, A. M. Vogel, W. A. Loenen and C. G. Figdor. 1994. Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 169:20126-20133.
11. Bakker, A. B., M. W. Schreurs, A. J. de Boer, Y. Kawakami, S. A. Rosenberg, G. J. Adema, and C. G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
12. Bakker, A. B., M. W. Schreurs, G. Tafazzul, A. J. de Boer, Y. Kawakami, G. J. Adema, and C. G. Figdor. 1995. Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2. 1-restricted anti-melanoma CTL line. Int. J. Cancer 62:97-102.
13. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette, E. Appella, and S. A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154:3961-3968.
14. Salgaller, M. L., A. Afshar, F. M. Marincola, L. Rivoltini, Y. Kawakami, and S. A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res. 55:4972-4979.
15. Zhai, Y., J. C. Yang, Y. Kawakami, P. Spiess, S. C. Wadsworth, L. M. Cardoza, L. A. Couture, A. E. Smith, and S. A. Rosenberg. 1996. Antigen-specific tumor vaccines: development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J. Immunol. 156:700-710.
16. Fahsold, R., H. D. Rott, and P. Lorenz. 1991. A third gene locus for tuberous sclerosis is closely linked to the phenylalanine hydroxylase gene locus. Hum. Genet. 88:85-90.
17. Sampson, J. R., and P. C. Harris. 1994. The molecular genetics of tuberous sclerosis. Hum. Mol. Genet. 3(Spec. No.): 1477-1480.
18. Kandt, R. S., J. L. Haines, M. Smith, H. Northrup, R. J. Gardner, M. P. Short, K. Dumars, E. S. Roach, S. Steingold, and S. Wall. 1992. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat. Genet. 2:37-41.
19. Smoller, B. R., A. Hsu, and J. Krueger. 1991. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J. Cutan. Pathol. 18:315-322.
20. Jimbow, K., S. K. Lee, M. G. King, H. Hara, H. Chen, J. Dakour, and H. Marusyk. 1993. Melanin pigments and malenosomal proteins as differentiation markers unique to normal and neoplastic melanocytes. J. Invest. Dermatol. 100:2598-2688.
21. Nine, J. S., S. A. Yousem, I. L. Paradis, R. Keenan, and B. P. Griffith. 1994. Lymphangioleiomyomatosis: recurrence after lung transplantation. J. Heart Lung Transplant. 13:714-719.
22. O'Brien, J. D., J. H. Lium, J. F. Parosa, B. R. Deyoung, M. R. Wick, and E. P. Trulock. 1995. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am. J. Respir. Crit. Care Med. 151:2033-2036.
23. Yockey, C. C., R. E. Riepe, and K. Ryan. 1986. Pulmonary lymphangioleiomyomatosis complicated by pregnancy. Kans. Med. 87:277-278, 293.
24. Hughes, E., and R. V. Hodder. 1987. Pulmonary lymphangiomyomatosis complicating pregnancy: a case report. J. Reprod. Med. 32:553-557.
25. Shen, A., M. D. Iseman, J. A. Waldron, and T. E. King. 1987. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 91:782-785.
26. Brentani, M. M., C. R. Carvalho, P. H. Saldiva, M. M. Pacheco, and C. T. Oshima. 1984. Steroid receptors in pulmonary lymphangiomyomatosis. Chest 85:96-99.
27. Ohori, N. P., S. A. Yousem, E. Sonmez-Alpan, and T. V. Colby. 1991. Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung. Am. J. Clin. Pathol. 96:529-535.
28. Berger, U., A. Khaghani, A. Pomerance, M. H. Yacoub, and R. C. Coombes. 1990. Pulmonary lymphangioleiomyomatosis and steroid receptors: an immunocytochemical study. Am. J. Clin. Pathol. 93: 609-614.
29. Kinoshita, M., T. Yokoyama, E. Higuchi, H. Yano, H. Watanabe, T. Rikimaru, Y. Ichikawa, and K. Oizumi. 1995. Hormone receptors in pulmonary lymphangiomyomatosis. Kurume. Med. J. 42:141-144.
30. Brown, M. 1994. Estrogen receptor molecular biology. Hematol. Oncol. Clin. North Am. 8:101-112.
31. Korach, K. S. 1994. Insights from the study of animals lacking functional estrogen receptor. Science 266(5190):1524-1527.
32. Chalbos, D., A. Philips, and H. Rochefort. 1994. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Semin. Cancer Biol. 5:361-368.
33. Ignar-Trowbridge, D. M., M. Pimentel, C. T. Teng, K. S. Korach, and J. A. McLachlan. 1995. Cross talk between peptide growth factor and estrogen receptor signaling systems. Environ. Health Perspect. 103(Suppl. 7):35-38.
34. Sourla, A., and M. Koutsilieris. 1995. Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts. J. Clin. Invest. 96:751-758.